BioCryst Pharmaceuticals, Inc.
CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR

Last updated:

Abstract:

Disclosed are crystalline salts of Compound I, methods of preparing them, and related pharmaceutical preparations thereof. Also disclosed are methods of treatment using the crystalline salts of the invention. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

2 Sep 2021

Issue date:

30 Jun 2022